Umer Raffat
Stock Analyst at Evercore ISI
(4.08)
# 1,609
Out of 4,456 analysts
158
Total ratings
48.6%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $87.89 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | n/a | $56.52 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $216.03 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $20.83 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $24.57 | - | 6 | May 11, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $127.88 | - | 15 | May 7, 2026 | |
| LLY Eli Lilly and Company | Maintained: Hold | n/a | $1,208.12 | - | 13 | May 4, 2026 | |
| AMGN Amgen | Maintained: Buy | n/a | $358.33 | - | 17 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Maintained: Hold | n/a | $6.77 | - | 6 | Apr 30, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $24.29 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.50 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.94 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.49 | +122.97% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.23 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.21 | - | 9 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $55.08 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $26.68 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $31.00 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.743 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.10 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.02 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $128.66 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.32 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.79 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $10.72 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $28.69 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.33 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $230.02 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $148.21 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.81 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $17.90 | n/a | 1 | Mar 9, 2018 |
Spyre Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $87.89
Upside: -
Vaxcyte
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $56.52
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $216.03
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $20.83
Upside: -
Elanco Animal Health
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $24.57
Upside: -
Gilead Sciences
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $127.88
Upside: -
Eli Lilly and Company
May 4, 2026
Maintained: Hold
Price Target: n/a
Current: $1,208.12
Upside: -
Amgen
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $358.33
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $6.77
Upside: -
Pfizer
Apr 27, 2026
Maintained: Buy
Price Target: n/a
Current: $24.29
Upside: -
Apr 10, 2026
Maintained: Hold
Price Target: n/a
Current: $13.50
Upside: -
Mar 27, 2026
Maintained: Buy
Price Target: n/a
Current: $35.94
Upside: -
Mar 9, 2026
Maintained: Buy
Price Target: $10
Current: $4.49
Upside: +122.97%
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $56.23
Upside: -
Nov 26, 2025
Maintained: Buy
Price Target: n/a
Current: $33.21
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: n/a
Current: $55.08
Upside: -
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $26.68
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $31.00
Upside: -
Sep 30, 2025
Maintained: Buy
Price Target: n/a
Current: $0.743
Upside: -
May 12, 2025
Maintained: Buy
Price Target: n/a
Current: $16.10
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $10.02
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $128.66
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $16.32
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.79
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $10.72
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $28.69
Upside: n/a
Dec 9, 2021
Maintained: Buy
Price Target: n/a
Current: $16.33
Upside: n/a
Jan 28, 2021
Maintained: Buy
Price Target: n/a
Current: $230.02
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $148.21
Upside: n/a
Jun 4, 2019
Maintained: Buy
Price Target: n/a
Current: $4.81
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $17.90
Upside: n/a